BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30807822)

  • 21. Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study.
    Sakellari I; Gavriilaki E; Chatziioannou K; Papathanasiou M; Mallouri D; Batsis I; Bousiou Z; Bouziana S; Constantinou V; Douka V; Apostolou C; Iskas M; Lalayanni C; Athanasiadou A; Sotiropoulos D; Yannaki E; Gianouzakos V; Anagnostopoulos A
    Ann Hematol; 2018 Oct; 97(10):1987-1994. PubMed ID: 29869673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of dose rate on pulmonary toxicity in patients with hematolymphoid malignancies undergoing total body irradiation.
    Kim DY; Kim IH; Yoon SS; Kang HJ; Shin HY; Kang HC
    Radiat Oncol; 2018 Sep; 13(1):180. PubMed ID: 30227866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia.
    Shigematsu A; Tanaka J; Suzuki R; Atsuta Y; Kawase T; Ito YM; Yamashita T; Fukuda T; Kumano K; Iwato K; Yoshiba F; Kanamori H; Kobayashi N; Fukuhara T; Morishima Y; Imamura M
    Int J Hematol; 2011 Nov; 94(5):463-71. PubMed ID: 22042561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of chemotherapeutic agents as a myeloablative conditioning with total body irradiation for pediatric acute lymphoblastic leukemia: A study from the pediatric ALL working group of the Japan Society for Hematopoietic Cell Transplantation.
    Kato M; Ishida H; Koh K; Inagaki J; Kato K; Goto H; Kaneko T; Cho Y; Hashii Y; Kurosawa H; Takita J; Hamamoto K; Inoue M; Sawada A; Suzuki R; Kato K
    Pediatr Blood Cancer; 2015 Oct; 62(10):1844-50. PubMed ID: 26053959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplantation conditioning regimens and outcomes after allogeneic hematopoietic cell transplantation in children and adolescents with acute lymphoblastic leukemia.
    Tracey J; Zhang MJ; Thiel E; Sobocinski KA; Eapen M
    Biol Blood Marrow Transplant; 2013 Feb; 19(2):255-9. PubMed ID: 23041605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addition of Thiotepa to Total Body Irradiation and Cyclophosphamide Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia.
    Chinnabhandar V; Tran S; Sutton R; Shaw PJ; Mechinaud F; Cole C; Tapp H; Teague L; Fraser C; O'Brien TA; Mitchell R;
    Biol Blood Marrow Transplant; 2020 Nov; 26(11):2068-2074. PubMed ID: 32736010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Favorable outcome of hematopoietic stem cell transplantation using a targeted once-daily intravenous busulfan-fludarabine-etoposide regimen in pediatric and infant acute lymphoblastic leukemia patients.
    Lee JW; Kang HJ; Kim S; Lee SH; Yu KS; Kim NH; Jang MK; Kim H; Song SH; Park JD; Park KD; Shin HY; Jang IJ; Ahn HS
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):190-5. PubMed ID: 25255163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation.
    Kim JH; Stein A; Tsai N; Schultheiss TE; Palmer J; Liu A; Rosenthal J; Forman SJ; Wong JY
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):75-81. PubMed ID: 24725691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia Treated with Total Body Irradiation-Free Allogeneic Hematopoietic Stem Cell Transplantation: Comparison of Patients with and Without Central Nervous System Involvement.
    Hamidieh AA; Monzavi SM; Kaboutari M; Behfar M; Esfandbod M
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2110-2117. PubMed ID: 28870778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study.
    Bunin N; Aplenc R; Kamani N; Shaw K; Cnaan A; Simms S
    Bone Marrow Transplant; 2003 Sep; 32(6):543-8. PubMed ID: 12953124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiotepa-Based Regimens Are Valid Alternatives to Total Body Irradiation-Based Reduced-Intensity Conditioning Regimens in Patients with Acute Lymphoblastic Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Battipaglia G; Labopin M; Mielke S; Ruggeri A; Nur Ozkurt Z; Bourhis JH; Rabitsch W; Yakoub-Agha I; Grillo G; Sanz J; Arcese W; Novis Y; Fegueux N; Spyridonidis A; Giebel S; Nagler A; Ciceri F; Mohty M
    Transplant Cell Ther; 2024 Jan; 30(1):95.e1-95.e10. PubMed ID: 37816471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiotepa-based versus total body irradiation-based myeloablative conditioning prior to allogeneic stem cell transplantation for acute myeloid leukaemia in first complete remission: a retrospective analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Eder S; Labopin M; Arcese W; Or R; Majolino I; Bacigalupo A; de Rosa G; Volin L; Beelen D; Veelken H; Schaap NP; Kuball J; Cornelissen J; Nagler A; Mohty M;
    Eur J Haematol; 2016 Jan; 96(1):90-7. PubMed ID: 25807864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total body irradiation compared with BEAM: Long-term outcomes of peripheral blood autologous stem cell transplantation for non-Hodgkin's lymphoma.
    Liu HW; Seftel MD; Rubinger M; Szwajcer D; Demers A; Nugent Z; Schroeder G; Butler JB; Cooke A
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):513-20. PubMed ID: 20137862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT.
    Pavlů J; Labopin M; Niittyvuopio R; Socié G; Yakoub-Agha I; Wu D; Remenyi P; Passweg J; Beelen DW; Aljurf M; Kröger N; Labussière-Wallet H; Perić Z; Giebel S; Nagler A; Mohty M
    J Hematol Oncol; 2019 Oct; 12(1):108. PubMed ID: 31647022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study.
    Peters C; Dalle JH; Locatelli F; Poetschger U; Sedlacek P; Buechner J; Shaw PJ; Staciuk R; Ifversen M; Pichler H; Vettenranta K; Svec P; Aleinikova O; Stein J; Güngör T; Toporski J; Truong TH; Diaz-de-Heredia C; Bierings M; Ariffin H; Essa M; Burkhardt B; Schultz K; Meisel R; Lankester A; Ansari M; Schrappe M; ; von Stackelberg A; ; Balduzzi A; ; Corbacioglu S; ; Bader P
    J Clin Oncol; 2021 Feb; 39(4):295-307. PubMed ID: 33332189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results.
    Kebriaei P; Bassett R; Lyons G; Valdez B; Ledesma C; Rondon G; Oran B; Ciurea S; Alousi A; Popat U; Patel K; Ahmed S; Olson A; Bashir Q; Shah N; Jones R; Marin D; Rezvani K; Nieto Y; Khouri I; Qazilbash M; Hosing C; Shpall E; Champlin RE; Andersson BS
    Biol Blood Marrow Transplant; 2017 Feb; 23(2):285-292. PubMed ID: 27816651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fludarabine, busulfan, and low-dose TBI conditioning versus cyclophosphamide and TBI in allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia.
    Speziali C; Daly A; Abuhaleeqa M; Nitta J; Abou Mourad Y; Seftel MD; Paulson K
    Leuk Lymphoma; 2019 Mar; 60(3):639-648. PubMed ID: 30160568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-Dose Daily Fractionation Is Not Inferior to Twice-a-Day Fractionated Total-Body Irradiation Before Allogeneic Stem Cell Transplantation for Acute Leukemia: A Useful Practice Simplification Resulting From the SARASIN Study.
    Belkacemi Y; Labopin M; Giebel S; Loganadane G; Miszczyk L; Michallet M; Socié G; Schaap NPM; Cornelissen JJ; Yakoub-Agha I; Polge E; Mohty M; Gorin NC; Nagler A;
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):515-526. PubMed ID: 29928948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Impact of Low-Dose Cranial Boost on the Long-Term Outcomes of Adult Patients with High-Risk Acute Lymphoblastic Leukemia Undergoing Total Body Irradiation and Allogeneic Hematopoietic Stem Cell Transplantation.
    Famoso JM; Grow JL; Laughlin B; Katsanis E; Stea B
    Pract Radiat Oncol; 2019 May; 9(3):e283-e289. PubMed ID: 30578956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia.
    Li QB; Li L; You Y; Chen ZC; Xia LH; Zou P
    Acta Pharmacol Sin; 2009 Oct; 30(10):1471-8. PubMed ID: 19767767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.